Alnylam Pharmaceuticals
ALNY
#550
Rank
โ‚ฌ37.10 B
Marketcap
280,83ย โ‚ฌ
Share price
-5.89%
Change (1 day)
5.71%
Change (1 year)
Alnylam Pharmaceuticals Inc. is a biopharmaceutical company focused on the R&D and commercialization of RNA interference (RNAi) therapeutics for genetically defined diseases.

We have found no stock splits for this company